Drug reference
viloxazine
NET Blocker, 5HT2B Receptor Antagonist, 5HT2C Receptor Agonist · ADHD treatment, Antidepressant
NET Blocker, 5HT2B Receptor Antagonist, 5HT2C Receptor AgonistADHD treatment, Antidepressant
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Originally thought to be a norepinephrine transporter (NET) blocker, it has more recently been determined to act as an antagonist of the 5HT2B receptor and as an agonist of the 5HT2C receptor.
Indications
Attention-deficit/hyperactivity disorder (ADHD)Depression
Related guidelines
Ask House about viloxazine
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team